| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.559 | 0.003 | 0.559 | Calcium channel activator | 0.528 0.004 CID_22011047 | ||
| 0.492 | 0.029 | 0.525 | 5 Hydroxytryptamine release stimulant | 0.525 0.023 CID_22011047 | CID_22011047 | |
| 0.457 | 0.006 | 0.484 | 5 Hydroxytryptamine uptake stimulant | 0.484 0.005 CID_22011047 | CID_22011047 | |
| 0.416 | 0.03 | 0.416 | Vasodilator, coronary | 0.381 0.042 CID_22011047 | ||
| 0.395 | 0.05 | 0.499 | Cholesterol antagonist | 0.499 0.033 CID_22011047 | CID_22011047 | |
| 0.294 | 0.004 | 0.294 | Sphingomyelinase inhibitor | 0.232 0.005 CID_22011047 | ||
| 0.314 | 0.027 | 0.446 | Tyrosine 3 hydroxylase inhibitor | 0.446 0.005 CID_22011047 | CID_22011047 | |
| 0.292 | 0.016 | 0.292 | Nav1.2 sodium channel blocker | 0.249 0.022 CID_22011047 | ||
| 0.332 | 0.058 | 0.372 | Spasmolytic | 0.372 0.046 CID_22011047 | CID_22011047 | |
| 0.355 | 0.084 | 0.355 | Calpain 2 inhibitor | 0.327 0.098 CID_22011047 | ||
| 0.269 | 0.003 | 0.269 | Glutamate (mGluR7) agonist | 0.181 0.005 CID_22011047 | ||
| 0.257 | 0.002 | 0.257 | Calcium-sensing receptor agonist | 0.139 0.003 CID_22011047 | ||
| 0.261 | 0.007 | 0.261 | Calcium antagonist | 0.115 0.038 CID_22011047 | ||
| 0.297 | 0.05 | 0.341 | Interleukin agonist | 0.341 0.032 CID_22011047 | CID_22011047 | |
| 0.279 | 0.039 | 0.279 | ErbB-1 antagonist | 0.268 0.043 CID_22011047 | ||
| 0.259 | 0.027 | 0.28 | Nitric-oxide synthase stimulant | 0.28 0.017 CID_22011047 | CID_22011047 | |
| 0.329 | 0.098 | 0.359 | Antiobesity | 0.359 0.083 CID_22011047 | CID_22011047 | |
| 0.225 | 0.013 | 0.225 | Nav1.6 sodium channel blocker | 0.187 0.025 CID_22011047 | ||
| 0.261 | 0.066 | 0.272 | Antiamyloidogenic | 0.272 0.062 CID_22011047 | CID_22011047 | |
| 0.323 | 0.14 | 0.356 | 5 Hydroxytryptamine release inhibitor | 0.356 0.11 CID_22011047 | CID_22011047 | |
| 0.273 | 0.096 | 0.347 | 12-Lipoxygenase inhibitor | 0.347 0.058 CID_22011047 | CID_22011047 | |
| 0.254 | 0.08 | 0.254 | Cardiotonic | 0.231 0.095 CID_22011047 | ||
| 0.235 | 0.064 | 0.25 | Psychostimulant | 0.25 0.058 CID_22011047 | CID_22011047 | |
| 0.19 | 0.023 | 0.19 | Neuropeptide Y1 antagonist | 0.189 0.024 CID_22011047 | ||
| 0.189 | 0.026 | 0.189 | Cathepsin H inhibitor | 0.188 0.026 CID_22011047 | ||
| 0.184 | 0.03 | 0.184 | Nav1.3 sodium channel blocker | 0.145 0.051 CID_22011047 | ||
| 0.202 | 0.051 | 0.202 | 3C-like protease (Human coronavirus) inhibitor | 0.153 0.097 CID_22011047 | ||
| 0.233 | 0.082 | 0.233 | Calpain inhibitor | 0.231 0.083 CID_22011047 | ||
| 0.17 | 0.02 | 0.196 | Papain-like protease (SARS coronavirus) inhibitor | 0.196 0.011 CID_22011047 | CID_22011047 | |
| 0.152 | 0.014 | 0.245 | Adrenaline agonist | 0.245 0.005 CID_22011047 | CID_22011047 | |
| 0.219 | 0.081 | 0.219 | Potassium channel blocker | |||
| 0.142 | 0.016 | 0.142 | Cannabinoid receptor antagonist | 0.128 0.019 CID_22011047 | ||
| 0.248 | 0.128 | 0.305 | Transcription factor NF kappa B inhibitor | 0.305 0.091 CID_22011047 | CID_22011047 | |
| 0.169 | 0.049 | 0.169 | Cytokine production inhibitor | 0.117 0.092 CID_22011047 | ||
| 0.127 | 0.009 | 0.158 | Beta 3 adrenoreceptor antagonist | 0.158 0.005 CID_22011047 | CID_22011047 | |
| 0.184 | 0.067 | 0.184 | Sigma receptor agonist | 0.159 0.079 CID_22011047 | ||
| 0.168 | 0.056 | 0.239 | Amylase inhibitor | 0.239 0.031 CID_22011047 | CID_22011047 | |
| 0.159 | 0.052 | 0.159 | Calcium channel blocker | |||
| 0.123 | 0.018 | 0.145 | Myeloperoxidase inhibitor | 0.145 0.012 CID_22011047 | CID_22011047 | |
| 0.115 | 0.014 | 0.149 | Sphingosine 1-phosphate receptor antagonist | 0.149 0.006 CID_22011047 | CID_22011047 | |
| 0.111 | 0.013 | 0.114 | Cannabinoid CB1 receptor antagonist | 0.114 0.013 CID_22011047 | CID_22011047 | |
| 0.121 | 0.024 | 0.121 | Rho-associated kinase II inhibitor | 0.084 0.042 CID_22011047 | ||
| 0.116 | 0.02 | 0.129 | Vanilloid agonist | 0.129 0.015 CID_22011047 | CID_22011047 | |
| 0.146 | 0.051 | 0.146 | Cyclooxygenase 3 inhibitor | 0.145 0.053 CID_22011047 | ||
| 0.123 | 0.028 | 0.15 | Lanosterol 14 alpha demethylase inhibitor | 0.15 0.012 CID_22011047 | CID_22011047 | |
| 0.108 | 0.014 | 0.129 | Beta adrenoreceptor antagonist | 0.129 0.008 CID_22011047 | CID_22011047 | |
| 0.205 | 0.112 | 0.226 | Superoxide dismutase inhibitor | 0.226 0.092 CID_22011047 | CID_22011047 | |
| 0.118 | 0.026 | 0.12 | Protein kinase B gamma inhibitor | 0.12 0.025 CID_22011047 | CID_22011047 | |
| 0.164 | 0.072 | 0.188 | Neurotensin receptor agonist | 0.188 0.042 CID_22011047 | CID_22011047 | |
| 0.232 | 0.141 | 0.282 | Antithrombotic | 0.282 0.101 CID_22011047 | CID_22011047 | |
| 0.091 | 0.005 | 0.091 | Acetyl-CoA carboxylase inhibitor | 0.084 0.007 CID_22011047 | ||
| 0.107 | 0.024 | 0.126 | Lipase inhibitor | 0.126 0.015 CID_22011047 | CID_22011047 | |
| 0.097 | 0.016 | 0.099 | Cannabinoid CB2 receptor antagonist | 0.099 0.015 CID_22011047 | CID_22011047 | |
| 0.103 | 0.023 | 0.125 | Sphingosine 1-phosphate receptor 4 agonist | 0.125 0.015 CID_22011047 | CID_22011047 | |
| 0.085 | 0.007 | 0.128 | Beta 2 adrenoreceptor agonist | 0.128 0.003 CID_22011047 | CID_22011047 | |
| 0.151 | 0.073 | 0.168 | CF transmembrane conductance regulator agonist | 0.168 0.049 CID_22011047 | CID_22011047 | |
| 0.082 | 0.004 | 0.099 | Methionyl aminopeptidase 1 inhibitor | 0.099 0.004 CID_22011047 | CID_22011047 | |
| 0.093 | 0.018 | 0.093 | Calcium channel T-type blocker | 0.062 0.035 CID_22011047 | ||
| 0.091 | 0.016 | 0.091 | Potassium channel (Tandem pore domain) blocker | 0.079 0.036 CID_22011047 | ||
| 0.115 | 0.041 | 0.115 | Nitric-oxide synthase inhibitor | 0.111 0.045 CID_22011047 | ||
| 0.079 | 0.005 | 0.079 | Parathyroid hormone antagonist | 0.079 0.005 CID_22011047 | ||
| 0.09 | 0.016 | 0.258 | NMDA 2A receptor antagonist | 0.258 0.004 CID_22011047 | CID_22011047 | |
| 0.079 | 0.007 | 0.079 | CC chemokine 4 receptor antagonist | 0.052 0.024 CID_22011047 | ||
| 0.223 | 0.152 | 0.304 | Interleukin 2 agonist | 0.304 0.071 CID_22011047 | CID_22011047 | |
| 0.133 | 0.062 | 0.135 | Vanilloid 1 agonist | 0.135 0.058 CID_22011047 | CID_22011047 | |
| 0.135 | 0.065 | 0.149 | Sphingosine 1-phosphate receptor 2 antagonist | 0.149 0.042 CID_22011047 | CID_22011047 | |
| 0.091 | 0.021 | 0.091 | Peroxisome proliferator-activated receptor gamma antagonist | 0.087 0.026 CID_22011047 | ||
| 0.162 | 0.092 | 0.185 | Succinate dehydrogenase inhibitor | 0.185 0.062 CID_22011047 | CID_22011047 | |
| 0.096 | 0.028 | 0.096 | 5 Hydroxytryptamine uptake inhibitor | 0.072 0.038 CID_22011047 | ||
| 0.127 | 0.06 | 0.127 | Sphingosine 1-phosphate receptor 4 antagonist | 0.126 0.062 CID_22011047 | ||
| 0.088 | 0.022 | 0.088 | Dopamine uptake inhibitor | 0.08 0.025 CID_22011047 | ||
| 0.108 | 0.042 | 0.319 | NMDA receptor antagonist | 0.319 0.005 CID_22011047 | CID_22011047 | |
| 0.126 | 0.062 | 0.126 | Anesthetic local | 0.114 0.071 CID_22011047 | ||
| 0.213 | 0.151 | 0.213 | Thyroid hormone antagonist | |||
| 0.142 | 0.081 | 0.142 | MAP kinase 3 inhibitor | 0.137 0.09 CID_22011047 | ||
| 0.074 | 0.016 | 0.113 | Sphingosine 1-phosphate receptor 1 antagonist | 0.113 0.007 CID_22011047 | CID_22011047 | |
| 0.092 | 0.034 | 0.092 | Purinergic P2X2 antagonist | 0.078 0.041 CID_22011047 | ||
| 0.097 | 0.04 | 0.097 | Inducible nitric-oxide synthase inhibitor | 0.091 0.046 CID_22011047 | ||
| 0.115 | 0.061 | 0.115 | Nav1.5 sodium channel blocker | |||
| 0.08 | 0.027 | 0.08 | Adrenaline uptake inhibitor | 0.077 0.029 CID_22011047 | ||
| 0.079 | 0.028 | 0.079 | 5 Hydroxytryptamine 2A agonist | 0.063 0.044 CID_22011047 | ||
| 0.056 | 0.005 | 0.056 | Acetyl-CoA carboxylase 2 inhibitor | 0.048 0.007 CID_22011047 | ||
| 0.157 | 0.107 | 0.157 | P-glycoprotein inhibitor | |||
| 0.059 | 0.01 | 0.059 | Diamine oxidase inhibitor | 0.04 0.023 CID_22011047 | ||
| 0.065 | 0.017 | 0.066 | Melanocortin 4 antagonist | 0.066 0.017 CID_22011047 | CID_22011047 | |
| 0.066 | 0.019 | 0.066 | Pregnane X receptor antagonist | 0.066 0.02 CID_22011047 | ||
| 0.194 | 0.147 | 0.243 | Lipoxygenase inhibitor | 0.243 0.105 CID_22011047 | CID_22011047 | |
| 0.084 | 0.038 | 0.084 | Epoxide hydrolase inhibitor | 0.077 0.045 CID_22011047 | ||
| 0.064 | 0.019 | 0.065 | Melanocortin antagonist | 0.065 0.018 CID_22011047 | CID_22011047 | |
| 0.088 | 0.044 | 0.11 | Estrogen-related receptor beta agonist | 0.11 0.015 CID_22011047 | CID_22011047 | |
| 0.066 | 0.022 | 0.067 | Epithelial sodium channel blocker | 0.067 0.02 CID_22011047 | CID_22011047 | |
| 0.055 | 0.011 | 0.055 | Potassium channel subfamily K member 3 blocker | 0.042 0.014 CID_22011047 | ||
| 0.111 | 0.068 | 0.111 | Calcium channel (voltage-sensitive) blocker | |||
| 0.084 | 0.042 | 0.084 | Rho-associated kinase I inhibitor | |||
| 0.054 | 0.013 | 0.085 | Beta adrenoreceptor agonist | 0.085 0.004 CID_22011047 | CID_22011047 | |
| 0.135 | 0.095 | 0.146 | Heat shock protein 70 antagonist | 0.146 0.057 CID_22011047 | CID_22011047 | |
| 0.061 | 0.021 | 0.063 | Vanilloid 2 antagonist | 0.063 0.019 CID_22011047 | CID_22011047 | |
| 0.186 | 0.148 | 0.217 | Neuropeptide Y2 antagonist | 0.217 0.093 CID_22011047 | CID_22011047 | |
| 0.188 | 0.152 | 0.197 | Transcription factor STAT3 inhibitor | 0.197 0.137 CID_22011047 | CID_22011047 | |
| 0.081 | 0.045 | 0.081 | Rho-associated kinase inhibitor | |||
| 0.066 | 0.031 | 0.066 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.044 | 0.009 | 0.044 | Melatonin antagonist | |||
| 0.067 | 0.034 | 0.067 | Calcium channel P-type blocker | |||
| 0.145 | 0.112 | 0.187 | Amyloid beta aggregation inhibitor | 0.187 0.085 CID_22011047 | CID_22011047 | |
| 0.118 | 0.086 | 0.118 | Sodium channel blocker | |||
| 0.043 | 0.011 | 0.043 | Melatonin receptor 1A agonist | |||
| 0.053 | 0.023 | 0.053 | CC chemokine 3 receptor antagonist | 0.039 0.031 CID_22011047 | ||
| 0.078 | 0.048 | 0.112 | Vanilloid antagonist | 0.112 0.031 CID_22011047 | CID_22011047 | |
| 0.066 | 0.037 | 0.132 | NMDA 2C receptor antagonist | 0.132 0.009 CID_22011047 | CID_22011047 | |
| 0.056 | 0.027 | 0.084 | Glycine transporter 2 inhibitor | 0.084 0.016 CID_22011047 | CID_22011047 | |
| 0.049 | 0.021 | 0.049 | GHS receptor agonist | 0.046 0.024 CID_22011047 | ||
| 0.172 | 0.144 | 0.234 | Peptidyltransferase inhibitor | 0.234 0.063 CID_22011047 | CID_22011047 | |
| 0.063 | 0.035 | 0.063 | Cathepsin L inhibitor | 0.062 0.037 CID_22011047 | ||
| 0.181 | 0.153 | 0.181 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.089 | 0.063 | 0.089 | Polo-like kinase-1 inhibitor | |||
| 0.158 | 0.132 | 0.291 | Aldehyde oxidase inhibitor | 0.291 0.069 CID_22011047 | CID_22011047 | |
| 0.041 | 0.014 | 0.041 | Melatonin agonist | |||
| 0.142 | 0.116 | 0.155 | ATPase inhibitor | 0.155 0.093 CID_22011047 | CID_22011047 | |
| 0.056 | 0.031 | 0.058 | Prostaglandin E2 antagonist | 0.058 0.03 CID_22011047 | CID_22011047 | |
| 0.048 | 0.024 | 0.055 | Cathepsin L2 inhibitor | 0.055 0.02 CID_22011047 | CID_22011047 | |
| 0.061 | 0.037 | 0.08 | Sphingosine 1-phosphate receptor 3 antagonist | 0.08 0.017 CID_22011047 | CID_22011047 | |
| 0.102 | 0.079 | 0.102 | Electron transport complex I inhibitor | |||
| 0.072 | 0.05 | 0.072 | Calcium channel L-type blocker | |||
| 0.227 | 0.206 | 0.316 | Analgesic | 0.316 0.129 CID_22011047 | CID_22011047 | |
| 0.093 | 0.071 | 0.113 | Chemokine receptor antagonist | 0.113 0.052 CID_22011047 | CID_22011047 | |
| 0.038 | 0.017 | 0.038 | Melatonin 1 agonist | |||
| 0.044 | 0.023 | 0.044 | Cathepsin F inhibitor | 0.044 0.023 CID_22011047 | ||
| 0.056 | 0.035 | 0.059 | Immunoglobulin Fc receptor antagonist | 0.059 0.028 CID_22011047 | CID_22011047 | |
| 0.044 | 0.023 | 0.045 | Factor VIIa inhibitor | 0.045 0.022 CID_22011047 | CID_22011047 | |
| 0.051 | 0.031 | 0.051 | Purinergic P2X antagonist | 0.046 0.037 CID_22011047 | ||
| 0.08 | 0.061 | 0.093 | Glutathione S-transferase inhibitor | 0.093 0.044 CID_22011047 | CID_22011047 | |
| 0.125 | 0.106 | 0.137 | Thiol protease inhibitor | 0.137 0.085 CID_22011047 | CID_22011047 | |
| 0.036 | 0.016 | 0.036 | Vanilloid 4 antagonist | 0.035 0.017 CID_22011047 | ||
| 0.04 | 0.021 | 0.04 | Bradykinin antagonist | 0.034 0.03 CID_22011047 | ||
| 0.129 | 0.113 | 0.154 | Interferon gamma antagonist | 0.154 0.073 CID_22011047 | CID_22011047 | |
| 0.03 | 0.015 | 0.035 | Prostaglandin EP4 antagonist | 0.035 0.013 CID_22011047 | CID_22011047 | |
| 0.116 | 0.101 | 0.127 | Neurotrophic factor | 0.127 0.085 CID_22011047 | CID_22011047 | |
| 0.048 | 0.033 | 0.048 | Glycine transporter inhibitor | |||
| 0.102 | 0.088 | 0.103 | MAO inhibitor | 0.103 0.088 CID_22011047 | CID_22011047 | |
| 0.043 | 0.029 | 0.049 | Glutamate (mGluR group III) agonist | 0.049 0.024 CID_22011047 | CID_22011047 | |
| 0.033 | 0.02 | 0.033 | GHS receptor antagonist | |||
| 0.067 | 0.054 | 0.096 | CXC chemokine receptor antagonist | 0.096 0.027 CID_22011047 | CID_22011047 | |
| 0.05 | 0.037 | 0.071 | Beta 2 adrenoreceptor antagonist | 0.071 0.016 CID_22011047 | CID_22011047 | |
| 0.072 | 0.061 | 0.087 | GABA B receptor agonist | 0.087 0.029 CID_22011047 | CID_22011047 | |
| 0.084 | 0.073 | 0.126 | HIV-1 integrase (Overall Integration) inhibitor | 0.126 0.036 CID_22011047 | CID_22011047 | |
| 0.036 | 0.025 | 0.044 | Ceramide glucosyltransferase inhibitor | 0.044 0.012 CID_22011047 | CID_22011047 | |
| 0.092 | 0.081 | 0.092 | Folate antagonist | 0.09 0.088 CID_22011047 | ||
| 0.095 | 0.085 | 0.125 | Nav1.4 sodium channel blocker | 0.125 0.048 CID_22011047 | CID_22011047 | |
| 0.02 | 0.01 | 0.02 | Complement factor D inhibitor | |||
| 0.024 | 0.014 | 0.037 | Beta 1 adrenoreceptor agonist | 0.037 0.005 CID_22011047 | CID_22011047 | |
| 0.034 | 0.025 | 0.04 | Phosphoglycerate kinase inhibitor | 0.04 0.019 CID_22011047 | CID_22011047 | |
| 0.028 | 0.019 | 0.028 | Bradykinin B1 receptor antagonist | |||
| 0.031 | 0.022 | 0.031 | CXC chemokine 3 receptor antagonist | |||
| 0.034 | 0.025 | 0.034 | Growth hormone secretagogue receptor antagonist | |||
| 0.12 | 0.112 | 0.137 | Anticoagulant | 0.137 0.092 CID_22011047 | CID_22011047 | |
| 0.2 | 0.192 | 0.2 | Ca(v)3.3 blocker | |||
| 0.037 | 0.03 | 0.037 | Cathepsin L1 inhibitor | |||
| 0.098 | 0.09 | 0.107 | Proteasome inhibitor | 0.107 0.078 CID_22011047 | CID_22011047 | |
| 0.052 | 0.045 | 0.056 | DNA helicase inhibitor | 0.056 0.034 CID_22011047 | CID_22011047 | |
| 0.052 | 0.044 | 0.067 | Beta 1 adrenoreceptor antagonist | 0.067 0.029 CID_22011047 | CID_22011047 | |
| 0.036 | 0.029 | 0.036 | Potassium channel Kv1.1 blocker | |||
| 0.186 | 0.179 | 0.259 | Insulysin inhibitor | 0.259 0.088 CID_22011047 | CID_22011047 | |
| 0.045 | 0.039 | 0.045 | Metalloproteinase-3 inhibitor | |||
| 0.049 | 0.044 | 0.052 | Human rhinovirus A protease inhibitor | 0.052 0.041 CID_22011047 | CID_22011047 | |
| 0.034 | 0.03 | 0.037 | Melanocortin 1 antagonist | 0.037 0.027 CID_22011047 | CID_22011047 | |
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.014 | 0.01 | 0.014 | Melatonin receptor 1A antagonist | |||
| 0.025 | 0.022 | 0.028 | Urotensin II agonist | 0.028 0.017 CID_22011047 | CID_22011047 | |
| 0.03 | 0.028 | 0.032 | Gonadotropin-releasing hormone receptor antagonist | 0.032 0.026 CID_22011047 | CID_22011047 | |
| 0.018 | 0.016 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 CID_22011047 | CID_22011047 | |
| 0.069 | 0.068 | 0.09 | Vanilloid 4 agonist | 0.09 0.026 CID_22011047 | CID_22011047 | |
| 0.013 | 0.013 | 0.014 | Integrin alpha4beta1 antagonist | 0.014 0.013 CID_22011047 | CID_22011047 | |
| 0.097 | 0.097 | 0.109 | Caspase 3 inhibitor | 0.109 0.078 CID_22011047 | CID_22011047 | |
| 0.042 | 0.041 | 0.042 | Dopamine transporter inhibitor | |||
| 0.078 | 0.078 | 0.131 | Potassium channel (Ca-activated) activator | 0.131 0.035 CID_22011047 | CID_22011047 | |
| 0.039 | 0.039 | 0.047 | GABA B receptor antagonist | 0.047 0.023 CID_22011047 | CID_22011047 | |
| 0.038 | 0.038 | 0.152 | NMDA receptor subunit 3B antagonist | 0.152 0.006 CID_22011047 | CID_22011047 | |
| 0.191 | 0.192 | 0.24 | Apoptosis antagonist | 0.24 0.138 CID_22011047 | CID_22011047 | |
| 0.022 | 0.023 | 0.024 | Melanocortin 5 antagonist | 0.024 0.02 CID_22011047 | CID_22011047 | |
| 0.124 | 0.126 | 0.143 | Melanin inhibitor | 0.143 0.091 CID_22011047 | CID_22011047 | |
| 0.024 | 0.027 | 0.038 | Glucagon receptor antagonist | 0.038 0.015 CID_22011047 | CID_22011047 | |
| 0.088 | 0.093 | 0.149 | Cystathionine beta-synthase inhibitor | 0.149 0.041 CID_22011047 | CID_22011047 | |
| 0.061 | 0.066 | 0.074 | Cathepsin G inhibitor | 0.074 0.049 CID_22011047 | CID_22011047 | |
| 0.057 | 0.066 | 0.183 | NMDA 2 receptor antagonist | 0.183 0.011 CID_22011047 | CID_22011047 | |
| 0.024 | 0.033 | 0.031 | Purinergic P2Y15 antagonist | 0.031 0.016 CID_22011047 | CID_22011047 | |
| 0.032 | 0.045 | 0.042 | Liver X receptor alpha agonist | 0.042 0.028 CID_22011047 | CID_22011047 | |
| 0.019 | 0.034 | 0.037 | Liver X receptor beta antagonist | 0.037 0.014 CID_22011047 | CID_22011047 | |
| 0.088 | 0.103 | 0.148 | DOPA decarboxylase inhibitor | 0.148 0.022 CID_22011047 | CID_22011047 | |
| 0.047 | 0.064 | 0.059 | Alpha 2 adrenoreceptor agonist | 0.059 0.044 CID_22011047 | CID_22011047 | |
| 0.136 | 0.153 | 0.163 | Hypolipemic | 0.163 0.125 CID_22011047 | CID_22011047 | |
| 0.028 | 0.046 | 0.033 | Glutamate (mGluR3) antagonist | 0.033 0.032 CID_22011047 | CID_22011047 | |
| 0.09 | 0.109 | 0.107 | TRPA1 agonist | 0.107 0.077 CID_22011047 | CID_22011047 | |
| 0.049 | 0.07 | 0.082 | NMDA receptor agonist | 0.082 0.027 CID_22011047 | CID_22011047 | |
| 0.034 | 0.055 | 0.048 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.048 0.018 CID_22011047 | CID_22011047 | |
| 0.063 | 0.085 | 0.073 | Protein kinase A inhibitor | 0.073 0.068 CID_22011047 | CID_22011047 | |
| 0.023 | 0.046 | 0.044 | ATP citrate lysase inhibitor | 0.044 0.01 CID_22011047 | CID_22011047 | |
| 0.054 | 0.077 | 0.073 | Potassium channel large-conductance Ca-activated activator | 0.073 0.041 CID_22011047 | CID_22011047 | |
| 0.185 | 0.212 | 0.229 | Immunosuppressant | 0.229 0.167 CID_22011047 | CID_22011047 | |
| 0.046 | 0.074 | 0.072 | Sphingosine kinase inhibitor | 0.072 0.023 CID_22011047 | CID_22011047 | |
| 0.092 | 0.12 | 0.125 | Toll-Like receptor 2 antagonist | 0.125 0.072 CID_22011047 | CID_22011047 | |
| 0.115 | 0.146 | 0.128 | Pregnane X receptor agonist | 0.128 0.106 CID_22011047 | CID_22011047 | |
| 0.096 | 0.128 | 0.136 | Histone deacetylase SIRT1 inhibitor | 0.136 0.074 CID_22011047 | CID_22011047 | |
| 0.012 | 0.045 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 CID_22011047 | CID_22011047 | |
| 0.127 | 0.163 | 0.179 | Phospholipase C inhibitor | 0.179 0.061 CID_22011047 | CID_22011047 | |
| 0.022 | 0.058 | 0.093 | NMDA receptor subunit 3A antagonist | 0.093 0.009 CID_22011047 | CID_22011047 | |
| 0.11 | 0.15 | 0.152 | Adenylate cyclase stimulant | 0.152 0.059 CID_22011047 | CID_22011047 | |
| 0.029 | 0.069 | 0.043 | Sphingosine kinase 1 inhibitor | 0.043 0.026 CID_22011047 | CID_22011047 | |
| 0.065 | 0.11 | 0.09 | Urease inhibitor | 0.09 0.079 CID_22011047 | CID_22011047 | |
| 0.073 | 0.12 | 0.092 | Bile acid receptor antagonist | 0.092 0.067 CID_22011047 | CID_22011047 | |
| 0.049 | 0.102 | 0.085 | Analgesic, opioid | 0.085 0.042 CID_22011047 | CID_22011047 | |
| 0.023 | 0.076 | 0.067 | Dopamine D5 agonist | 0.067 0.009 CID_22011047 | CID_22011047 | |
| 0.039 | 0.093 | 0.06 | Botulinum neurotoxin type A inhibitor | 0.06 0.038 CID_22011047 | CID_22011047 | |
| 0.031 | 0.086 | 0.043 | CF transmembrane conductance regulator antagonist | 0.043 0.018 CID_22011047 | CID_22011047 | |
| 0.035 | 0.09 | 0.052 | CXC chemokine 4 receptor antagonist | 0.052 0.05 CID_22011047 | CID_22011047 | |
| 0.18 | 0.236 | 0.344 | GABA C receptor rho-3 antagonist | 0.344 0.089 CID_22011047 | CID_22011047 | |
| 0.054 | 0.12 | 0.089 | Opioid kappa receptor antagonist | 0.089 0.047 CID_22011047 | CID_22011047 | |
| 0.202 | 0.27 | 0.324 | Calcium channel L-type activator | 0.324 0.137 CID_22011047 | CID_22011047 | |
| 0.091 | 0.16 | 0.136 | Diuretic | 0.136 0.089 CID_22011047 | CID_22011047 | |
| 0.082 | 0.152 | 0.12 | Interleukin 8 antagonist | 0.12 0.062 CID_22011047 | CID_22011047 | |
| 0.066 | 0.137 | 0.121 | Chelator | 0.121 0.052 CID_22011047 | CID_22011047 | |
| 0.069 | 0.14 | 0.096 | Histone deacetylase class III inhibitor | 0.096 0.094 CID_22011047 | CID_22011047 | |
| 0.055 | 0.128 | 0.081 | 5-Lipoxygenase inhibitor | 0.081 0.079 CID_22011047 | CID_22011047 | |
| 0.01 | 0.084 | 0.029 | CXC chemokine 2 receptor antagonist | 0.029 0.015 CID_22011047 | CID_22011047 | |
| 0.104 | 0.182 | 0.122 | Sphingosine 1-phosphate receptor 5 antagonist | 0.122 0.121 CID_22011047 | CID_22011047 | |
| 0.052 | 0.131 | 0.097 | Opioid antagonist | 0.097 0.05 CID_22011047 | CID_22011047 | |
| 0.048 | 0.134 | 0.08 | Histamine N-methyltransferase inhibitor | 0.08 0.067 CID_22011047 | CID_22011047 | |
| 0.054 | 0.14 | 0.082 | Estrogen receptor alpha antagonist | 0.082 0.046 CID_22011047 | CID_22011047 | |
| 0.045 | 0.134 | 0.075 | GABA aminotransferase inhibitor | 0.075 0.054 CID_22011047 | CID_22011047 | |
| 0.03 | 0.121 | 0.052 | CXC chemokine 1 receptor antagonist | 0.052 0.034 CID_22011047 | CID_22011047 | |
| 0.116 | 0.213 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.114 CID_22011047 | CID_22011047 | |
| 0.191 | 0.288 | 0.265 | Cyclophilin D inhibitor | 0.265 0.196 CID_22011047 | CID_22011047 | |
| 0.038 | 0.138 | 0.077 | Aminopeptidase I inhibitor | 0.077 0.045 CID_22011047 | CID_22011047 | |
| 0.064 | 0.163 | 0.089 | CC chemokine 5 receptor agonist | 0.089 0.04 CID_22011047 | CID_22011047 | |
| 0.091 | 0.192 | 0.121 | Growth hormone agonist | 0.121 0.12 CID_22011047 | CID_22011047 | |
| 0.106 | 0.208 | 0.197 | Immunostimulant | 0.197 0.122 CID_22011047 | CID_22011047 | |
| 0.026 | 0.13 | 0.069 | Opioid mu receptor antagonist | 0.069 0.047 CID_22011047 | CID_22011047 | |
| 0.11 | 0.214 | 0.183 | Neurotrophic factor enhancer | 0.183 0.094 CID_22011047 | CID_22011047 | |
| 0.022 | 0.127 | 0.061 | Opioid delta receptor antagonist | 0.061 0.046 CID_22011047 | CID_22011047 | |
| 0.016 | 0.121 | 0.039 | Oxytocin agonist | 0.039 0.033 CID_22011047 | CID_22011047 | |
| 0.069 | 0.179 | 0.11 | Aldehyde dehydrogenase inhibitor | 0.11 0.083 CID_22011047 | CID_22011047 | |
| 0.085 | 0.2 | 0.124 | Farnesoid X receptor antagonist | 0.124 0.095 CID_22011047 | CID_22011047 | |
| 0.055 | 0.171 | 0.093 | Anabolic | 0.093 0.073 CID_22011047 | CID_22011047 | |
| 0.058 | 0.181 | 0.108 | GABA C receptor antagonist | 0.108 0.067 CID_22011047 | CID_22011047 | |
| 0.141 | 0.282 | 0.211 | 15-Lipoxygenase inhibitor | 0.211 0.201 CID_22011047 | CID_22011047 | |
| 0.04 | 0.185 | 0.089 | Aminopeptidase B inhibitor | 0.089 0.073 CID_22011047 | CID_22011047 | |
| 0.072 | 0.227 | 0.127 | Cell wall synthesis inhibitor | 0.127 0.09 CID_22011047 | CID_22011047 | |
| 0.136 | 0.295 | 0.222 | Sodium/bile acid cotransporter inhibitor | 0.222 0.159 CID_22011047 | CID_22011047 | |
| 0.064 | 0.232 | 0.161 | Peroxidase inhibitor | 0.161 0.073 CID_22011047 | CID_22011047 | |
| 0.087 | 0.256 | 0.162 | Free radical scavenger | 0.162 0.132 CID_22011047 | CID_22011047 | |
| 0.059 | 0.23 | 0.128 | Estrogen antagonist | 0.128 0.042 CID_22011047 | CID_22011047 | |
| 0.021 | 0.224 | 0.078 | Phenylalanine 4-hydroxylase inhibitor | 0.078 0.039 CID_22011047 | CID_22011047 | |
| 0.042 | 0.254 | 0.113 | Estrogen receptor beta antagonist | 0.113 0.041 CID_22011047 | CID_22011047 | |
| 0.032 | 0.281 | 0.116 | Creatine kinase inhibitor | 0.116 0.044 CID_22011047 | CID_22011047 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |